EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells

Shuo Huang(Zhejiang Chinese Medical University), Bo Zhu(Huaian First People’s Hospital)
Cancer Research
February 8, 2019
Cited by 183


Related Papers